Randomized phase II cross-over sequential chemotherapy trial of irinotecan/cisplatin (IP) vs. gemcitabine/vinorelbine (GV) in chemo-naive patients with stage IIIb/IV non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Lee, J. S. [1 ]
Lee, D. H. [1 ]
Lee, J. J. [1 ]
Han, J. Y. [1 ]
Park, S. H. [1 ]
Song, J. E. [1 ]
Kim, H. Y. [1 ]
Kim, H. T. [1 ]
机构：
[1] Natl Canc Ctr Hosp, Goyang Gyeonggi, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7134
引用
收藏
页码：397S / 397S
页数：1
相关论文
共 50 条
  • [1] A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC)
    Grigorescu, Alexandru
    Ciuleanu, Tudor
    Firoiu, Elena
    Muresan, Delia Ruta
    Teodorescu, Gabriela
    Basson, Bruce R.
    LUNG CANCER, 2007, 57 (02) : 168 - 174
  • [2] A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)
    Ginopoulos, P
    Mastronikolis, NS
    Giannios, J
    Karana, A
    Siabi, V
    Karvelas, F
    Rathossis, S
    Apostolopoulos, N
    Mastorakou, A
    LUNG CANCER, 1999, 23 (01) : 31 - 37
  • [3] A phase II randomized trial of vinorelbine plus cisplatin or docetaxel plus cisplatin in inoperable, chemo-naive non-small cell lung cancer patients
    Chen, Y
    Shih, J
    Tsai, C
    Perng, R
    Whang-Peng, J
    LUNG CANCER, 2005, 49 : S389 - S389
  • [4] Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC):: a multicentre phase II clinical trial
    Palmeri, S
    Leonardi, V
    Gebbia, V
    De Bella, MT
    Ferraù, F
    Faillù, G
    Spatafora, M
    Valenza, R
    Di Vita, G
    Vitello, S
    Carroccio, R
    Sciortino, G
    Vaglica, M
    Accurso, V
    Agostara, B
    Licata, G
    LUNG CANCER, 2001, 34 (01) : 115 - 123
  • [5] Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer:: a phase III randomized trial
    Zatloukal, P
    Petruzelka, L
    Zemanová, M
    Kolek, V
    Skricková, J
    Pesek, M
    Fojtu, H
    Grygárková, I
    Sixtová, D
    Roubec, J
    Horenková, E
    Havel, L
    Prusa, P
    Nováková, L
    Skácel, T
    Kuta, M
    LUNG CANCER, 2003, 41 (03) : 321 - 331
  • [6] Randomized phase II study of cisplatin/vinorelbine vs cisplatin/gemcitabine vs vinorelbine/gemcitabine in patients with advanced non-small cell lung cancer
    Tsai, CM
    Perng, RP
    Wang, GS
    Chen, YM
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 78 - 78
  • [7] A multicenter phase II trial with gemcitabine (GEM) and vinorelbine (VNR) in the treatment of non-small cell lung cancer (NSCLC) stage IIIB and IV
    Laack, E
    Mende, T
    Saal, JG
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Dalhoff, K
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S252 - S252
  • [8] Gemcitabine (G) as a single drug versus gemcitabine plus vinorelbine (GV) for non-small cell lung cancer (NSCLC) stage IIIB and IV
    Alberto, S
    Raquel, G
    Alberto, V
    LUNG CANCER, 2005, 49 : S388 - S389
  • [9] A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
    Chen, Yuh-Min
    Perng, Reury-Perng
    Shih, Jen-Fu
    Whang-Peng, Jacqueline
    LUNG CANCER, 2008, 61 (02) : 214 - 219
  • [10] Randomized Phase II Trial of NGR-hTNF and Chemotherapy in Chemo-naive Patients With Non-small Cell Lung Cancer (NSCLC) - Preliminary Results
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    Rossoni, G.
    Pietrantonio, F.
    Rijavec, E.
    Citterio, G.
    Platania, M.
    Lambiase, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S596 - S596
12345